| 1 |
35255429 |
10.1016/j.anndiagpath.2021.151886 |
2022 |
De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients. |
ACTB |
| 2 |
35344115 |
10.1007/s11033-022-07337-w |
2022 |
Identification and validation of suitable housekeeping genes for gene expression studies in BCR-ABL1 positive B-lineage acute lymphoblastic leukemia. |
ACTB |
| 3 |
35765478 |
10.14202/vetworld.2022.1333-1340 |
2022 |
Investigation of proteomic profiles in canine lymphoma using tandem mass tag-based quantitative proteomics approach. |
ACTB |
| 4 |
33404293 |
10.1080/15548627.2020.1871204 |
2021 |
BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes. |
ACTB |
| 5 |
33952317 |
10.1186/s13148-021-01091-9 |
2021 |
Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors. |
ACTB |
| 6 |
34598060 |
10.1016/j.ctarc.2021.100465 |
2021 |
Prioritising breast cancer theranostics: A current medical longing in oncology. |
ACTB |
| 7 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
ACTB |
| 8 |
31242129 |
10.1080/15548627.2019.1635380 |
2020 |
<i>MIR145-3p</i> promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting <i>HDAC4</i>. |
ACTB |
| 9 |
32349449 |
10.3390/ijms21093093 |
2020 |
Prevalence of Cytoplasmic Actin Mutations in Diffuse Large B-Cell Lymphoma and Multiple Myeloma: A Functional Assessment Based on Actin Three-Dimensional Structures. |
ACTB |
| 10 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
ACTB |
| 11 |
31108950 |
10.3390/genes10050376 |
2019 |
Identification and Validation of Novel Reference Genes in Acute Lymphoblastic Leukemia for Droplet Digital PCR. |
ACTB |
| 12 |
29433359 |
10.1080/15548627.2017.1390636 |
2018 |
Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. |
ACTB |
| 13 |
27868373 |
10.1002/ajmg.a.38057 |
2017 |
Acute myeloid leukemia in Baraitser-Winter cerebrofrontofacial syndrome. |
ACTB |
| 14 |
28807016 |
10.1186/s12885-017-3536-6 |
2017 |
Endogenous controls of gene expression in N-methyl-N-nitrosourea-induced T-cell lymphoma in p53-deficient mice. |
ACTB |
| 15 |
26852652 |
10.1016/j.bcmd.2015.11.006 |
2016 |
ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia. |
ACTB |
| 16 |
25052316 |
10.1038/ejhg.2014.95 |
2015 |
Baraitser-Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 cases. |
ACTB |
| 17 |
25696013 |
NA |
2015 |
Selection of superior reference genes' combination for quantitative real-time PCR in B-cell lymphomas. |
ACTB |
| 18 |
25715028 |
10.1080/15548627.2015.1017191 |
2015 |
BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. |
ACTB |
| 19 |
25984893 |
10.1080/15548627.2015.1034402 |
2015 |
The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells. |
ACTB |
| 20 |
26043155 |
10.1080/15548627.2015.1055439 |
2015 |
TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy. |
ACTB |
| 21 |
24275555 |
10.1016/j.bbadis.2013.11.021 |
2014 |
Peri-conceptional obesogenic exposure induces sex-specific programming of disease susceptibilities in adult mouse offspring. |
ACTB |
| 22 |
24418552 |
10.1016/j.virol.2013.11.022 |
2014 |
HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics. |
ACTB |
| 23 |
23266771 |
10.1016/j.cca.2012.12.012 |
2013 |
ACTB in cancer. |
ACTB |
| 24 |
23326330 |
10.1371/journal.pone.0052384 |
2013 |
Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25. |
ACTB |
| 25 |
23849470 |
10.1186/1756-8722-6-52 |
2013 |
Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner. |
ACTB |
| 26 |
22343534 |
10.1073/pnas.1121343109 |
2012 |
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. |
ACTB |
| 27 |
19309015 |
10.1002/elps.200800508 |
2009 |
2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma. |
ACTB |
| 28 |
20031021 |
10.1016/j.rbmo.2009.09.024 |
2009 |
Apoptosis in normal ovaries of women with and without endometriosis. |
ACTB |
| 29 |
17823310 |
10.1182/blood-2007-04-087775 |
2007 |
HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration. |
ACTB |
| 30 |
16105984 |
10.1182/blood-2005-03-1204 |
2005 |
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. |
ACTB |
| 31 |
1505215 |
10.1159/000133336 |
1992 |
Sublocalization of an invasion-inducing locus and other genes on human chromosome 7. |
ACTB |
| 32 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
ARID1A |
| 33 |
34560683 |
10.1097/PAS.0000000000001813 |
2022 |
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. |
ARID1A |
| 34 |
34649275 |
10.1182/bloodadvances.2021005316 |
2022 |
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity. |
ARID1A |
| 35 |
34791836 |
10.1002/cam4.4422 |
2022 |
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. |
ARID1A |
| 36 |
35038193 |
10.1111/his.14617 |
2022 |
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. |
ARID1A |
| 37 |
35054466 |
10.3390/life12010073 |
2022 |
The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma. |
ARID1A |
| 38 |
35172382 |
10.1002/JLB.5A0721-361R |
2022 |
Genomic heterogeneity contributed to different prognosis between adult and pediatric acute lymphoblastic. |
ARID1A |
| 39 |
35317330 |
10.14740/wjon1436 |
2022 |
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. |
ARID1A |
| 40 |
35454811 |
10.3390/cancers14081904 |
2022 |
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. |
ARID1A |
| 41 |
35727053 |
10.1002/cncr.34348 |
2022 |
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. |
ARID1A |
| 42 |
35794096 |
10.1038/s41467-022-31355-8 |
2022 |
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. |
ARID1A |
| 43 |
35879731 |
10.1186/s40364-022-00401-4 |
2022 |
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma. |
ARID1A |
| 44 |
36001451 |
10.1097/PAS.0000000000001956 |
2022 |
Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas. |
ARID1A |
| 45 |
33431788 |
10.1038/s41392-020-00437-8 |
2021 |
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. |
ARID1A |
| 46 |
33829512 |
10.1111/his.14378 |
2021 |
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma. |
ARID1A |
| 47 |
34039950 |
10.1038/s41408-021-00493-5 |
2021 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
ARID1A |
| 48 |
34070951 |
10.3390/diagnostics11060999 |
2021 |
Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma. |
ARID1A |
| 49 |
34348985 |
10.1136/jclinpath-2021-207441 |
2021 |
Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours. |
ARID1A |
| 50 |
31423576 |
10.1111/bjh.16159 |
2020 |
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy. |
ARID1A |
| 51 |
32083995 |
10.1200/JCO.19.02314 |
2020 |
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies. |
ARID1A |
| 52 |
32918521 |
10.1002/pbc.28704 |
2020 |
Aggressive Langerhans cell histiocytosis following T-cell acute lymphoblastic leukemia. |
ARID1A |
| 53 |
32978169 |
10.1158/0008-5472.CAN-20-2147 |
2020 |
EZH2-Targeted Therapies in Cancer: Hype or a Reality. |
ARID1A |
| 54 |
33252851 |
10.1002/ctm2.221 |
2020 |
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. |
ARID1A |
| 55 |
33376237 |
10.1038/s41392-020-00331-3 |
2020 |
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma. |
ARID1A |
| 56 |
30886885 |
10.1016/j.gore.2019.02.007 |
2019 |
Endometrial cancer arising after complete remission of uterine malignant lymphoma: A case report and mutation analysis. |
ARID1A |
| 57 |
31123138 |
10.1136/jclinpath-2019-205727 |
2019 |
Intravascular NK/T-cell lymphoma: clinicopathological and integrated molecular analysis of two cases provides a clue to disease pathogenesis. |
ARID1A |
| 58 |
31300419 |
10.1182/bloodadvances.2018029546 |
2019 |
Sporadic and endemic Burkitt lymphoma have frequent <i>FOXO1</i> mutations but distinct hotspots in the AKT recognition motif. |
ARID1A |
| 59 |
31747604 |
10.1016/j.celrep.2019.10.083 |
2019 |
Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas. |
ARID1A |
| 60 |
29307627 |
10.1016/j.humpath.2017.12.025 |
2018 |
Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant. |
ARID1A |
| 61 |
29486633 |
10.1177/1533034618754475 |
2018 |
Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma. |
ARID1A |
| 62 |
29669287 |
10.1016/j.celrep.2018.03.078 |
2018 |
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer. |
ARID1A |
| 63 |
29989027 |
10.18632/oncotarget.25601 |
2018 |
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. |
ARID1A |
| 64 |
30134235 |
10.1159/000492835 |
2018 |
Frequent Mutations in Natural Killer/T Cell Lymphoma. |
ARID1A |
| 65 |
30190015 |
10.1016/j.hoc.2018.05.007 |
2018 |
Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond. |
ARID1A |
| 66 |
27872090 |
10.1158/0008-5472.CAN-16-1303 |
2017 |
Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia. |
ARID1A |
| 67 |
28401006 |
NA |
2017 |
Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors. |
ARID1A |
| 68 |
29025291 |
10.1556/650.2017.30868 |
2017 |
[Waldenström's macroglobulinemia and its individualized therapy options]. |
ARID1A |
| 69 |
29222279 |
10.1182/asheducation-2017.1.358 |
2017 |
Follicular lymphoma: are we ready for a risk-adapted approach? |
ARID1A |
| 70 |
26839360 |
10.1136/thoraxjnl-2015-207950 |
2016 |
A patient with complex multiple genomic ALK alterations. |
ARID1A |
| 71 |
27102345 |
10.1038/modpathol.2016.79 |
2016 |
Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. |
ARID1A |
| 72 |
27590521 |
10.18632/oncotarget.11773 |
2016 |
Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes. |
ARID1A |
| 73 |
27729836 |
10.5808/GI.2016.14.3.78 |
2016 |
Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel. |
ARID1A |
| 74 |
25444907 |
10.1016/j.canlet.2014.11.024 |
2015 |
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. |
ARID1A |
| 75 |
25779943 |
10.1158/1078-0432.CCR-14-2759 |
2015 |
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. |
ARID1A |
| 76 |
25918285 |
10.1200/JCO.2014.59.2444 |
2015 |
Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing. |
ARID1A |
| 77 |
26192917 |
10.1038/ng.3358 |
2015 |
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma. |
ARID1A |
| 78 |
26256760 |
10.1016/S1470-2045(15)00169-2 |
2015 |
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. |
ARID1A |
| 79 |
26415585 |
10.1038/ncomms9470 |
2015 |
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome. |
ARID1A |
| 80 |
26446488 |
10.1038/ncomms9325 |
2015 |
LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. |
ARID1A |
| 81 |
26468873 |
10.1371/journal.ppat.1005158 |
2015 |
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. |
ARID1A |
| 82 |
26473533 |
10.1038/bcj.2015.89 |
2015 |
Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas. |
ARID1A |
| 83 |
26551670 |
10.1038/ng.3444 |
2015 |
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. |
ARID1A |
| 84 |
24366360 |
10.1182/blood-2013-09-525808 |
2014 |
The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. |
ARID1A |
| 85 |
24435047 |
10.1182/blood-2013-05-500264 |
2014 |
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. |
ARID1A |
| 86 |
23292937 |
10.1073/pnas.1205299110 |
2013 |
Genetic heterogeneity of diffuse large B-cell lymphoma. |
ARID1A |
| 87 |
22585168 |
10.1158/2159-8290.CD-11-0208 |
2012 |
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. |
ARID1A |
| 88 |
22915242 |
10.1007/s00428-012-1303-2 |
2012 |
ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability. |
ARID1A |
| 89 |
22931316 |
10.1056/NEJMoa1200710 |
2012 |
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. |
ARID1A |
| 90 |
23091298 |
10.1182/blood-2012-06-437624 |
2012 |
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. |
ARID1A |
| 91 |
23143597 |
10.1038/ng.2468 |
2012 |
The genetic landscape of mutations in Burkitt lymphoma. |
ARID1A |
| 92 |
21590771 |
10.1002/path.2911 |
2011 |
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. |
ARID1A |
| 93 |
19066270 |
10.1093/jnci/djn416 |
2008 |
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. |
ARID1A |
| 94 |
33788417 |
10.1002/pbc.29036 |
2021 |
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. |
ARID5B |
| 95 |
33891562 |
10.18632/aging.202903 |
2021 |
Age-related differences of genetic susceptibility to patients with acute lymphoblastic leukemia. |
ARID5B |
| 96 |
31573954 |
10.1158/1078-0432.CCR-19-0190 |
2020 |
<i>ARID5B</i> Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia. |
ARID5B |
| 97 |
31704777 |
10.1136/jmedgenet-2019-106339 |
2020 |
Novel phenotypes observed in patients with <i>ETV6</i>-linked leukaemia/familial thrombocytopenia syndrome and a biallelic <i>ARID5B</i> risk allele as leukaemogenic cofactor. |
ARID5B |
| 98 |
31870219 |
10.1080/08880018.2019.1705949 |
2020 |
Association of <i>ABCC2</i> with levels and toxicity of methotrexate in Malaysian Childhood Acute Lymphoblastic Leukemia (ALL). |
ARID5B |
| 99 |
32488880 |
10.1002/jcla.23414 |
2020 |
Association of TLX1 gene polymorphisms with the risk of acute lymphoblastic leukemia and B lineage acute lymphoblastic leukemia in Han Chinese children. |
ARID5B |
| 100 |
30770347 |
10.1158/1055-9965.EPI-18-0801 |
2019 |
Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype. |
ARID5B |
Datasets
Models
